0.56

1.75% -0.010

Galmed Pharmaceuticals Ltd (GLMD)

Überblick Nachrichten Preisverlauf Warum fällt GLMD? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$0.57

Offen:

$0.559

24-Stunden-Volumen:

25,421

Relative Volume:

0.01

Marktkapitalisierung:

$4.30M

Einnahmen:

Nettoeinkommen (Verlust:

$-10.31M

KGV:

-0.2403

EPS:

-2.3308

Netto-Cashflow:

$-6.32M

1W Leistung:

-1.82%

1M Leistung:

+6.67%

6M Leistung:

-32.77%

1J Leistung:

-72.41%

1-Tages-Spanne:

$0.542

$0.57

1-Wochen-Bereich:

$0.5403

$0.5749

52-Wochen-Spanne:

$0.4111

$2.34

Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile

Firmenname

Galmed Pharmaceuticals Ltd

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

Adresse

Mitarbeiter

Twitter

@GalmedPharma

Nächster Verdiensttermin

2026-08-27

Neueste SEC-Einreichungen

GLMD's Discussions on Twitter

Compare GLMD vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GLMD Galmed Pharmaceuticals Ltd	0.56	4.30M	0	-10.31M	-6.32M	-2.3308
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-05-22	Herabstufung	B. Riley FBR	Buy → Neutral
2020-02-04	Eingeleitet	Craig Hallum	Buy
2020-01-30	Fortgesetzt	Cantor Fitzgerald	Overweight
2019-12-02	Eingeleitet	Canaccord Genuity	Buy
2018-12-12	Eingeleitet	B. Riley FBR	Buy
2018-08-02	Bestätigt	Maxim Group	Buy
2018-07-13	Eingeleitet	Stifel	Buy
2018-07-12	Eingeleitet	Cantor Fitzgerald	Overweight
2018-06-12	Bestätigt	H.C. Wainwright	Buy
2018-03-15	Hochstufung	Maxim Group	Hold → Buy
2018-02-14	Herabstufung	Maxim Group	Buy → Hold
2018-02-12	Bestätigt	H.C. Wainwright	Buy
2017-11-15	Eingeleitet	ROTH Capital	Buy
2017-08-08	Bestätigt	H.C. Wainwright	Buy
2017-07-31	Bestätigt	Maxim Group	Buy
2016-08-01	Bestätigt	Maxim Group	Buy
2016-07-06	Fortgesetzt	ROTH Capital	Buy
2016-03-28	Fortgesetzt	H.C. Wainwright	Buy
2015-06-23	Eingeleitet	H.C. Wainwright	Buy
2015-05-06	Eingeleitet	Sun Trust Rbsn Humphrey	Buy

Alle ansehen

Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten

Jul 08, 2026

Galmed Pharmaceuticals Reports Wider Q1 2026 Loss Amid Higher R&D Spending - TipRanks

Jul 08, 2026

Galmed (NASDAQ: GLMD) posts Q1 loss and closes Colospan acquisition - Stock Titan

Jul 08, 2026

Jul 07, 2026

Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market - AOL.com

Jul 07, 2026

Jul 03, 2026

Galmed Pharmaceuticals (GLMD) Plunges Nearly 12% as Stock Tests Key Support at $0.54Trading Ideas - dars.gov.et

Jul 03, 2026

Jul 02, 2026

Galmed Pharmaceuticals (GLMD) Slides 12% as Selling Pressure Intensifies Near Key SupportMarket Neutral Pair - dars.gov.et

Jul 02, 2026

Jun 26, 2026

Enterprise value to EBITDA forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD - TradingView

Jun 25, 2026

Price to book forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD - TradingView

Jun 25, 2026

Price to sales forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD - TradingView

Jun 25, 2026

Enterprise value to EBIT forward of Galmed Pharmaceuticals Ltd. – NASDAQ:GLMD - TradingView

Jun 25, 2026

Jun 23, 2026

Galmed Pharmaceuticals Closes Amended All-Cash Colospan Acquisition With Earnout Structure - The Globe and Mail

Jun 23, 2026

Jun 22, 2026

Galmed completes acquisition of medical device firm Colospan - Investing.com UK

Jun 22, 2026

Galmed Pharmaceuticals finishes restructured Colospan deal - grafa.com

Jun 22, 2026

Form 6K Galmed Pharmaceuticals Ltd For: 22 June By Investing.com - Investing.com Nigeria

Jun 22, 2026

Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms For Colospan Ltd. - TradingView

Jun 22, 2026

Galmed completes acquisition of medical device firm Colospan By Investing.com - Investing.com Nigeria

Jun 22, 2026

Galmed (NASDAQ: GLMD) closes Colospan acquisition; $3.3M cash, up to $2M earnout - Stock Titan

Jun 22, 2026

Galmed (NASDAQ: GLMD) completes Colospan acquisition with cash and earnout - Stock Titan

Jun 22, 2026

Galmed buys CG-100 maker Colospan, eyes faster EU sales - Stock Titan

Jun 22, 2026

Jun 18, 2026